|
|
||||||||
The Journal of Immunology, Vol 153, Issue 5 2194-2203, Copyright © 1994 by American Association of Immunologists
ARTICLES |
YA Mekori and DD Metcalfe
Department of Medicine, Meir Hospital Kfar-Saba, Tel-Aviv University, Israel.
IL-3-dependent mast cells undergo apoptosis upon removal of IL-3, an event that is prevented by the addition of stem cell factor (SCF) acting through its receptor c-kit, suggesting that SCF provides a mechanism to allow mast cells to survive and to differentiate in tissues in the relative absence of IL-3. This observation is consistent with the thesis that the microenvironment, in part, controls mast cell number and viability by modulating SCF production and release. The purpose of the present study was to determine whether a second factor, TGF-beta 1, was capable of modifying the SCF-mediated survival pathway. TGF-beta 1 (1 and 10 ng/ml), known to be an important regulator of cell growth and function, did inhibit the SCF-mediated rescue from apoptosis in IL-3-deprived mast cells. TGF-beta 1 exerted its inhibitory effect on SCF-mediated rescue from apoptosis, even when added 4 h after the addition of SCF. In contrast, TGF-beta 1 had no substantial effect on the viability of mast cells that were grown in the presence of IL-3. TGF-beta 1 also had no noticeable effect on viability and proliferation of a growth factor-independent mast cell line. The inhibitory effect of TGF-beta 1 was neutralized by specific anti-TGF-beta mAb. TGF-beta 1 did not affect the expression of c-kit, as determined by using flow cytometric analysis of mast cells labeled with FITC-conjugated anti-c- kit. These results demonstrate how SCF and TGF-beta may act in concert to regulate mast cell numbers under physiologic or pathologic conditions.
This article has been cited by other articles:
![]() |
T Gebhardt, A Lorentz, F Detmer, C Trautwein, H Bektas, M P Manns, and S C Bischoff Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor {beta}1 Gut, July 1, 2005; 54(7): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gomez, C. D. Ramirez, J. Rivera, M. Patel, F. Norozian, H. V. Wright, M. V. Kashyap, B. O. Barnstein, K. Fischer-Stenger, L. B. Schwartz, et al. TGF-{beta}1 Inhibits Mast Cell Fc{epsilon}RI Expression J. Immunol., May 15, 2005; 174(10): 5987 - 5993. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Gurish, P. J. Bryce, H. Tao, A. B. Kisselgof, E. M. Thornton, H. R. Miller, D. S. Friend, and H. C. Oettgen IgE Enhances Parasite Clearance and Regulates Mast Cell Responses in Mice Infected with Trichinella spiralis J. Immunol., January 15, 2004; 172(2): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Gurish, H. Tao, J. P. Abonia, A. Arya, D. S. Friend, C. M. Parker, and K. F. Austen Intestinal Mast Cell Progenitors Require CD49d{beta}7 ({alpha}4{beta}7 Integrin) for Tissue-specific Homing J. Exp. Med., October 29, 2001; 194(9): 1243 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Olsson, A-K Ulfgren, and G Nilsson Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients Ann Rheum Dis, March 1, 2001; 60(3): 187 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Sanchez Mejia, B. K. Lam, and J. P. Arm Matrix-Associated Transforming Growth Factor-beta 1 Primes Mouse Bone Marrow-Derived Mast Cells for Increased High-Affinity Fc Receptor for Immunoglobulin E-Dependent Eicosanoid Biosynthesis Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 557 - 565. [Abstract] [Full Text] |
||||
![]() |
H. R.P. Miller, S. H. Wright, P. A. Knight, and E. M. Thornton A Novel Function for Transforming Growth Factor-{beta}1: Upregulation of the Expression and the IgE-Independent Extracellular Release of a Mucosal Mast Cell Granule-Specific {beta}-Chymase, Mouse Mast Cell Protease-1 Blood, May 15, 1999; 93(10): 3473 - 3486. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Fang, P. J. Wolters, M. Steinhoff, A. Bidgol, J. L. Blount, and G. H. Caughey Mast Cell Expression of Gelatinases A and B Is Regulated by kit Ligand and TGF-{beta} J. Immunol., May 1, 1999; 162(9): 5528 - 5535. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |